Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

723 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The three Es of cancer immunoediting.
Dunn GP, Old LJ, Schreiber RD. Dunn GP, et al. Among authors: old lj. Annu Rev Immunol. 2004;22:329-60. doi: 10.1146/annurev.immunol.22.012703.104803. Annu Rev Immunol. 2004. PMID: 15032581 Review.
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.
Nicholaou T, Chen W, Davis ID, Jackson HM, Dimopoulos N, Barrow C, Browning J, Macgregor D, Williams D, Hopkins W, Maraskovsky E, Venhaus R, Pan L, Hoffman EW, Old LJ, Cebon J. Nicholaou T, et al. Among authors: old lj. Cancer Immunol Immunother. 2011 Nov;60(11):1625-37. doi: 10.1007/s00262-011-1041-3. Epub 2011 Jun 23. Cancer Immunol Immunother. 2011. PMID: 21698545 Clinical Trial.
Cancer Vaccine Collaborative 2002: opening address.
Old LJ. Old LJ. Cancer Immun. 2003 Feb 6;3 Suppl 1:1. Cancer Immun. 2003. PMID: 12747742 No abstract available.
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD. Kaplan DH, et al. Among authors: old lj. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7556-61. doi: 10.1073/pnas.95.13.7556. Proc Natl Acad Sci U S A. 1998. PMID: 9636188 Free PMC article.
Eradication of established tumors by CD8+ T cell adoptive immunotherapy.
Hanson HL, Donermeyer DL, Ikeda H, White JM, Shankaran V, Old LJ, Shiku H, Schreiber RD, Allen PM. Hanson HL, et al. Among authors: old lj. Immunity. 2000 Aug;13(2):265-76. doi: 10.1016/s1074-7613(00)00026-1. Immunity. 2000. PMID: 10981969
Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.
Dighe AS, Richards E, Old LJ, Schreiber RD. Dighe AS, et al. Among authors: old lj. Immunity. 1994 Sep;1(6):447-56. doi: 10.1016/1074-7613(94)90087-6. Immunity. 1994. PMID: 7895156
Signaling and signaling dysfunction through the interferon gamma receptor.
Rodig S, Kaplan D, Shankaran V, Old L, Schreiber RD. Rodig S, et al. Eur Cytokine Netw. 1998 Sep;9(3 Suppl):49-53. Eur Cytokine Netw. 1998. PMID: 9831186 Review. No abstract available.
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, Shea LK, Hundal J, Wendl MC, Demeter R, Wylie T, Allison JP, Smyth MJ, Old LJ, Mardis ER, Schreiber RD. Matsushita H, et al. Among authors: old lj. Nature. 2012 Feb 8;482(7385):400-4. doi: 10.1038/nature10755. Nature. 2012. PMID: 22318521 Free PMC article.
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
Schreiber RD, Old LJ, Smyth MJ. Schreiber RD, et al. Among authors: old lj. Science. 2011 Mar 25;331(6024):1565-70. doi: 10.1126/science.1203486. Science. 2011. PMID: 21436444 Review.
Adaptive immunity maintains occult cancer in an equilibrium state.
Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD. Koebel CM, et al. Among authors: old lj. Nature. 2007 Dec 6;450(7171):903-7. doi: 10.1038/nature06309. Epub 2007 Nov 18. Nature. 2007. PMID: 18026089
723 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback